Immuneering Corporation Class A (IMRX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$4.26−$0.0800 (−1.84%) on the dayAs of the close; data may be delayed.
IMRX price, last 12 months
Key stats
- Previous close
- $4.34
- Open
- $4.40
- Day range
- $4.26 – $4.40
- 52-week range
- $3.86 – $9.60
- Volume
- 466.3K
- Avg volume (20 days)
- 715.9K
- Market cap
- $276.3M
Performance
1W−4.9%
1M−17.3%
3M−10.5%
6M−18.4%
YTD−35.3%
1Y−53.9%
vs S&P 500, 1Y−70.6 pts
Technicals and fundamentals
About Immuneering Corporation Class A
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $276.3M